Description
The 8th International Symposium on Targeted Anticancer Therapies (TAT 2010) will cover the most promising new drug targets and drugs affecting these targets. TAT 2010 will provide overviews - in keynotes and expert reviews - of drug development by molecular target but also presentations of recent results of early-phase clinical studies with particular targeted agents. In addition, the program will feature combinations of targeted agents with each other or with other treatment modalities, as well as updates on approved targeted agents, preclinical target identification and validation, preclinical drug profiles, biomarker studies, methodology of anticancer drug development and regulatory issues in anticancer drug development.
